C2N Diagnostics services

C2N has a long, established history of collaborating with and providing bioanalytical service to many pharmaceutical companies, biotechnology companies, and leading scientists at academic institutions throughout the world. Our services are based upon our proprietary Stable Isotope Labeling Kinetic (SILK™) and Stable Isotope Spike Absolute Quantification (SISAQ™) Platforms. We perform pharmacokinetic (PK) and pharmacodynamic (PD) analyses in humans and animal models of disease, ranging from preclinical proof-of-principle studies to phase 3 clinical trials. These services are performed using our existing proprietary assays as well as custom-developed assays targeting analytes of interest to our customers and collaborators.